7 May 2024 – EyRIS had a great day hosting an EMBA delegation from William & Mary | Raymond A. Mason School of Business, a distinguished public research university and the 2nd oldest institution of higher learning located in Williamsburg, Virginia. WM’s Executive MBA is designed for focused, driven leaders who are positioned to move into senior executive and C-suite…
NOVA MSC BERHAD 03 May 2024 1. Details of Corporate Proposal Involve issuance of new type/class of securities ? No Types of corporate proposal Conversion of Preference Shares Details of corporate proposal Conversion of Irredeemable Convertible Preference Shares No. of shares issued under this corporate proposal 422,000 Issue price per share ($$) Malaysian Ringgit (MYR) 0.0400 Par Value($$) (if…
24 Apr 2024 – It is estimated that Brunei Darussalam has a diabetes prevalence of about 13% and evidence reveals that 1 in 3 diabetic patients develops diabetic retinopathy, which left untreated can lead to blindness. This morning, Jerudong Park Medical Centre (JPMC) launched the SELENA+ Artificial Intelligence Diabetic Retinopathy Screening Service – the first AI eye screening service in…
21 Apr 2024 – Nova MSC provided eye screening for the members of Diabetes Malaysia (Penang Branch) during their Annual General Meeting (AGM) in Penang Adventist Hospital (PAH). With the help from Diabetes Malaysia, we have managed to screen more than 20 of their members for eye diseases using SELENA+ an advanced diagnostic tool to autonomously detect diabetic retinopathy, glaucoma…
NOVA MSC BERHAD 19 April 2024 Type Announcement Subject OTHERS Description Nova MSC Berhad (NOVAMSC or Company) Term Sheets With Jostar Investment VCC 1. Introduction The Board of Directors of NOVAMSC wishes to announce the execution of the following Term Sheets by its subsidiary companies on 19 April 2024: (i) Term Sheet between Dex-Lab Pte. Ltd. (“Dex-Lab”), a 60%…
NOVA MSC BERHAD 17 April 2024 1. Details of Corporate Proposal Involve issuance of new type/class of securities ? No Types of corporate proposal Conversion of Preference Shares Details of corporate proposal Conversion of Irredeemable Convertible Preference Shares No. of shares issued under this corporate proposal 610,000 Issue price per share ($$) Malaysian Ringgit (MYR) 0.0400 Par Value($$) (if…
15 Apr 2024 – EyRIS is thrilled to announce our partnership with iCare in support of Sight For All’s mission to combat preventable blindness in Mongolia. We are humbled to be invited to participate in this meaningful community outreach project by way of contributing our flagship product SELENA+, an advanced diagnostic tool to autonomously detect diabetic retinopathy, glaucoma and Aged-Related…
NOVA MSC BERHAD 08 April 2024 1. Details of Corporate Proposal Involve issuance of new type/class of securities ? No Types of corporate proposal Conversion of Preference Shares Details of corporate proposal Conversion of Irredeemable Convertible Preference Shares No. of shares issued under this corporate proposal 30,000 Issue price per share ($$) Malaysian Ringgit (MYR) 0.0400 Par Value($$)…
28 Mar 2024 – Professor Wynne Hsu, leading the Institute of Data Science at the National University of Singapore, is a key figure in data science and AI in healthcare, focusing on developing new machine learning techniques for real-world applications. Her significant contributions include SELENA+, a deep learning-based solution for the screening of eye disease (diabetic retinopathy, glaucoma, cataract) from…
NOVA MSC BERHAD 26 March 2024 1. Details of Corporate Proposal Involve issuance of new type/class of securities ? No Types of corporate proposal Conversion of Preference Shares Details of corporate proposal Conversion of Irredeemable Convertible Preference Shares No. of shares issued under this corporate proposal 323,000 Issue price per share ($$) Malaysian Ringgit (MYR) 0.0400 Par Value($$) (if…
NOVA MSC BERHAD 21 March 2024 1. Details of Corporate Proposal Involve issuance of new type/class of securities ? No Types of corporate proposal Conversion of Preference Shares Details of corporate proposal Conversion of Irredeemable Convertible Preference Shares No. of shares issued under this corporate proposal 1,973,300 Issue price per share ($$) Malaysian Ringgit (MYR) 0.0400 Par Value($$) (if…
20 Mar 2024 – Since 1987, the Kasih Ibu Hospital (KIH) group has gained a strong reputation for providing quality and affordable medical care in a modern setting aided by advanced diagnostic equipment. To-date, the group has expanded to four different sites, making it the hospital with the widest reach in Bali. In 2018, KIH chose to implement VESALIUS hospital…